Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized Trial
Samaher Ashram, Houda Bahig, Aisling Barry, Denise Blanchette, Anders Celinksi, Peter Chung, Johnson Darko, David Donath, Robert Doucet, Abigail Erickson, Meredith Giuliani, Darin Gopaul, Scott Hipwell, Joanna Javor, Joda Kuk, Patricia Lindsay, Barbara Millman, Michael R. Oliver, Andrew Pearce, Catherine Russell, Sashendra Senthi, Toni Vu, Andrew Warner, Stewart Gaede, David A. Palma
Topics & Concepts
MedicineSABR volatility modelRandomized controlled trialRadiation therapyRadiosurgeryOncologyInternal medicineVolatility (finance)Stochastic volatilityEconomicsFinancial economicsAdvanced Radiotherapy TechniquesLung Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications